No Picture
Trading Ideas

The Race Continues for a COVID-19 Vaccine; 3 Healthcare Stocks to Watch

The question keeping the world up at night: when will a COVID-19 vaccine be ready? Since China released the virus’ genetic sequence on January 10, researchers in several countries have been working around the clock to develop an effective and safe vaccine. Even though the rapid pace of the development process has been impressive to say the least, patience is required as the task at hand certainly won’t be an easy one.However, in recent days, a few healthcare companies have made strides in the advancement of a COVID-19 vaccine, inspiring hope that we are well on our way to stamping …read more […]

No Picture
Trading Ideas

Athersys Jumps More Than 20% After FDA Approves MultiStem Coronavirus Study

Shares in Athersys, Inc. (ATHX) soared more than 20% in U.S. premarket trading after the biotech company announced that it was granted approval by the Food and Drug Administration (FDA) to start a pivotal clinical study of its stem-cell therapy on patients with COVID-19-induced acute respiratory distress syndrome (ARDS).Following the FDA approval, Athersys said it plans this quarter to initiate a phase 2/3 pivotal study to determine the safety and efficacy of its MultiStem therapy in coroanavirus patients with moderate to severe acute respiratory distress syndrome. The study conducted among 400 individuals will be administered at leading pulmonary critical care …read more […]